Some clinical reports [1] showed that MLL partner genes were the main determinants of leukemia phenotype, and MLL-AF4 was mainly associated with lymphoid malignancies, while MLL-AF9 was more likely to cause myeloid malignancies, which might may explain why MLL-AF4 was most common in ALL. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.